143 related articles for article (PubMed ID: 26065354)
1. Effect of Oral Pilocarpine in Treating Severe Dry Eye in Patients With Sjögren Syndrome.
Kawakita T; Shimmura S; Tsubota K
Asia Pac J Ophthalmol (Phila); 2015; 4(2):101-5. PubMed ID: 26065354
[TBL] [Abstract][Full Text] [Related]
2. Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome.
Yokoi N; Sonomura Y; Kato H; Komuro A; Kinoshita S
Eye (Lond); 2015 Sep; 29(9):1204-12. PubMed ID: 26160526
[TBL] [Abstract][Full Text] [Related]
3. Oral pilocarpine for the treatment of dry eye in patients with Sjögren's syndrome.
Felberg S; Dantas PEC; Sato EH
Arq Bras Oftalmol; 2022; 85(3):269-276. PubMed ID: 34909917
[TBL] [Abstract][Full Text] [Related]
4. Visante optical coherence tomography and tear function test evaluation of cholinergic treatment response in patients with sjögren syndrome.
Ibrahim OM; Dogru M; Kawashima S; Wakamatsu TH; Tsubota K; Fujishima H
Cornea; 2013 May; 32(5):653-7. PubMed ID: 23146930
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Autologous Serum Eye Drops Combined With Punctal Plugs for the Treatment of Sjögren Syndrome-Related Dry Eye.
Liu Y; Hirayama M; Cui X; Connell S; Kawakita T; Tsubota K
Cornea; 2015 Oct; 34(10):1214-20. PubMed ID: 26226470
[TBL] [Abstract][Full Text] [Related]
6. [Autologous serum tears: Long-term treatment in dry eye syndrome].
Beylerian M; Lazaro M; Magalon J; Veran J; Darque A; Grimaud F; Stolowy N; Beylerian H; Sabatier F; Hoffart L
J Fr Ophtalmol; 2018 Mar; 41(3):246-254. PubMed ID: 29602451
[TBL] [Abstract][Full Text] [Related]
7. Association between systemic activity ındex and dry eye severity in patients with primary Sjögren syndrome.
Ozek D; Kemer OE; Omma A
Arq Bras Oftalmol; 2019; 82(1):45-50. PubMed ID: 30403265
[TBL] [Abstract][Full Text] [Related]
8. Oral pilocarpine for the treatment of ocular symptoms in patients with Sjögren's syndrome: a randomised 12 week controlled study.
Tsifetaki N; Kitsos G; Paschides CA; Alamanos Y; Eftaxias V; Voulgari PV; Psilas K; Drosos AA
Ann Rheum Dis; 2003 Dec; 62(12):1204-7. PubMed ID: 14644860
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Sjögren's syndrome dry eye using 0.03% tacrolimus eye drop: Prospective double-blind randomized study.
Moscovici BK; Holzchuh R; Sakassegawa-Naves FE; Hoshino-Ruiz DR; Albers MB; Santo RM; Hida RY
Cont Lens Anterior Eye; 2015 Oct; 38(5):373-8. PubMed ID: 25956572
[TBL] [Abstract][Full Text] [Related]
10. Conjunctival epithelium improvement after systemic pilocarpine in patients with Sjogren's syndrome.
Aragona P; Di Pietro R; Spinella R; Mobrici M
Br J Ophthalmol; 2006 Feb; 90(2):166-70. PubMed ID: 16424527
[TBL] [Abstract][Full Text] [Related]
11. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome.
Yoon KC; Heo H; Im SK; You IC; Kim YH; Park YG
Am J Ophthalmol; 2007 Jul; 144(1):86-92. PubMed ID: 17493572
[TBL] [Abstract][Full Text] [Related]
12. The Efficacy of Diquafosol Ophthalmic Solution in Non-Sjögren and Sjögren Syndrome Dry Eye Patients Unresponsive to Artificial Tear.
Jeon HS; Hyon JY
J Ocul Pharmacol Ther; 2016 Sep; 32(7):463-8. PubMed ID: 27294831
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the clinical course of dry eye syndrome.
Horwath-Winter J; Berghold A; Schmut O; Floegel I; Solhdju V; Bodner E; Schwantzer G; Haller-Schober EM
Arch Ophthalmol; 2003 Oct; 121(10):1364-8. PubMed ID: 14557170
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Cortisol Phosphate in Hyaluronic Acid Vehicle in the Treatment of Dry Eye in Sjogren Syndrome.
Rolando M; Vagge A
J Ocul Pharmacol Ther; 2017 Jun; 33(5):383-390. PubMed ID: 28375792
[TBL] [Abstract][Full Text] [Related]
15. Aggravated dry eye after laser in situ keratomileusis in patients with Sjögren syndrome.
Liang L; Zhang M; Zou W; Liu Z
Cornea; 2008 Jan; 27(1):120-3. PubMed ID: 18245981
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effect of topical tacrolimus 0.03% versus cyclosporine 0.05% in the treatment of dry eye secondary to Sjogren syndrome.
Moawad P; Shamma R; Hassanein D; Ragab G; El Zawahry O
Eur J Ophthalmol; 2022 Jan; 32(1):673-679. PubMed ID: 33530719
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the first tear film break-up point in Sjögren's syndrome and non-Sjögren's syndrome dry eye patients.
Zhao S; Le Q
BMC Ophthalmol; 2022 Jan; 22(1):1. PubMed ID: 34980014
[TBL] [Abstract][Full Text] [Related]
18. Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia in Sjögren syndrome: a double-blind randomized controlled trial.
Cifuentes M; Del Barrio-Díaz P; Vera-Kellet C
Br J Dermatol; 2018 Nov; 179(5):1056-1061. PubMed ID: 29432648
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Sjögren's syndrome-associated dry eye an evidence-based review.
Akpek EK; Lindsley KB; Adyanthaya RS; Swamy R; Baer AN; McDonnell PJ
Ophthalmology; 2011 Jul; 118(7):1242-52. PubMed ID: 21459453
[TBL] [Abstract][Full Text] [Related]
20. Elevation of autophagy markers in Sjögren syndrome dry eye.
Byun YS; Lee HJ; Shin S; Chung SH
Sci Rep; 2017 Dec; 7(1):17280. PubMed ID: 29222450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
